Table 3 and its visualisation in Figure 6 display the results. It is clear that model performance does not decay as the cancer diagnosis becomes more distant from the time the analysed mammogram was taken. Interestingly, there is a significant reduction for earlier cancer groups, particularly those in Interval 1, but analysing results from BCR-priors in Figure 7, which constitutes of cases from those exact groups, we can see that the model has strong predictive power in these scenarios. The gene discussed is BCR; the disease is cancer.